d of pg studies. introduction gene therapy and use chromosome intro. steps of gene therapy ...
TRANSCRIPT
GENE THERAPY
D of PG Studies
GENE THERAPY 2
Introduction Gene therapy and use Chromosome intro. Steps of gene therapy Types Problems Current status Conclusion References
Objectives-
GENE THERAPY 3
Gene - A segment of DNA found on a chromosome that codes for a particular protein.
Humans have approximately 100,000 genes.
Genome - The sum of all genes that code for a particular organism.
Gene & Genome-
Are carried on a chromosome
The basic unit of heredity
Encode how to make a protein◦ DNARNA proteins
Proteins carry out most of life’s function.
When altered causes dysfunction of a protein
Genes-
Gene therapy = Introduction of normal genes into cells that contain defective genes to reconstitute a missing protein product
GT is used to correct a deficient phenotype so that sufficient amounts of a normal gene product are synthesized to improve a genetic disorder
A. What is gene therapy? Why is it used?
GENE THERAPY 6
Structure of a Chromosome
GENE THERAPY 7
Disease Genetic defect
hemophilia A absence of clotting factor VIII
hemophilia B absence of clotting factor IX
cystic fibrosis defective chloride channel protein
muscular dystrophy
defective muscle protein (dystrophin)
sickle-cell disease
defective beta globin
Many human diseases are caused by defective genes
GENE THERAPY 8
The Beginning…
In the 1980s, Scientists began to look into gene therapy.
They would insert human genes into a bacterial cell.
Then the bacterial cell would transcribe and translate the
information .
Then they would introduce the protein into human cells.
GENE THERAPY 9
What is Gene Therapy
It is a technique for correcting defective genes that are
responsible for disease development.
OR
The treatment of disease by either replacing damaged
or abnormal genes with normal ones, or by providing
new genetic instructions to help fight disease.
Modification of somatic cells by transferring desired gene sequences into the genome.
Somatic cells necessary to ensure that inserted genes are not carried over to the next generation.
How is Gene Therapy Carried Out?
GENE THERAPY 11
How It Works
A vector delivers the therapeutic gene into a patient’s target cell
The target cells become infected with the viral vector
The vector’s genetic material is inserted into the target cell
Functional proteins are created causing the cell to return to a
normal state
GENE THERAPY 12
How It Works…….
13
Steps in Gene Therapy
GENE THERAPY 14
The First Case,
The first gene therapy was performed on September 14th, 1990.
Ashanti DeSilva was treated for SCID.
Doctors removed her white blood cells,inserted the missing gene into the
WBC, and then put them back into her blood stream. This strengthened her
immune system, Only worked for a few months.
GENE THERAPY 15
A gene is inserted into the DNA of the germline cells (egg or sperm) so that the offspring of the patient will have the inserted gene.
The egg is a very large cell, relatively easy to manipulate and inject with DNA.
Inherited by the next generation.
Approaches: Germline therapy
GENE THERAPY 16
Somatic cells include all the non-reproductive cells in the
human body. Not inherited by the next generation. e.g:- bone marrow cells, blood cells, skin cells etc.
Somatic Gene Therapy
GENE THERAPY 17
Technique of Somatic Therapy
GENE THERAPY 18
Gene transfer
Vectors - Gene therapy delivery vehicles, or carriers, that encapsulate therapeutic genes for delivery to cells.Examples
Biological (Viral vectors, mammalian chromosomes etc)Physical (Microinjection, Gene gun, naked ‘DNA’, Electroporation etc)Chemical (Liposomes, Oligonucleotides etc)
GENE THERAPY 19
Different Delivery Systems are Available
In vivo = delivery of genes takes
place in the body
Ex vivo = delivery takes place out of
the body, and then cells are placed back into the body
GENE THERAPY 20
In vivo GENE THERAPY
Gene therapy is a technique for correcting defective genes responsible for disease development. Researchers may use one of several approaches for correcting faulty genes:
21
GENE THERAPY 22
Viruses
Replicate by inserting their DNA into a host cell. Gene therapy can use this to insert genes that encode for
a desired protein to create the desired trait. The virus is engineered so that it cannot reproduce. Four different types 1) Retroviruses 2) Adenoviruses 3) Adeno-associated Viruses 4) Herpes Simplex Viruses
GENE THERAPY 23
Can't "expand" to fit a piece of genetic material larger than it is naturally built to carry, some genes may be too big to fit into a certain type of virus.
Viruses can cause immune responses in patients, resulting in two potential outcomes:
Patients may get sick.A patient's immunity to a virus may limit treatments.
General drawbacks of Viral Vectors
GENE THERAPY 24
More efficient to deliver a gene using a non-viral vector, which has fewer size constraints and which won't generate an immune response
Typically circular DNA molecules- Plasmids Bacteria use plasmids to transfer genes from cell to cell Easily and efficiently store and replicate genes of interest
from any organism
Non-Viral Vectors
GENE THERAPY 25
No immune response.Could carry a lot of information i.e one or more therapeutic genes.
Chromosome
GENE THERAPY 26
General advantages of viral vectors They are very good at targeting and entering cells. Some viral vectors might be engineered to target specific types
of cells. They can be modified so that they can't replicate and destroy
the cell.
Viral Vectors
GENE THERAPY 27
Gene guns Isolate normal DNA fragment. Make very small spheres of a heavy metal like gold. Coat gold with DNA. Fire particles at cells at high speed so particles enter cells. May be used directly on tissues or organs in situ.
Other techniques… a) Electoporation b)Liposomes
Gene guns
GENE THERAPY 28
Problems with Gene Therapy
Short Lived ◦ Hard to rapidly integrate therapeutic DNA into genome
and rapidly dividing nature of cells prevent gene therapy for long time.
◦ Have multiple rounds of therapy.
Viral VectorsPatient could have toxic, immune, inflammatory response
GENE THERAPY 29
Multigene DisordersHard to treat because need to introduce more than one
gene. Immune Response
New things introduced leads to immune responseMay induce a tumor if integrated in a tumor suppressor
gene because insertional mutagenesis.
PROBLEMS CONT…..
GENE THERAPY 30
Current Status FDA hasn’t approved any human gene therapy product for
saleReasons: In 1999, 18-year-old Jesse Gelsinger died from multiple
organ failure 4 days after treatment for ornithine transcarboxylase deficiency.
January 2003, halt to using retrovirus vectors in blood stem cells because children developed leukemia-like condition after successful treatment for X-linked severe combined immunodeficiency disease.
GENE THERAPY 31
Successful Gene Therapy
Severe Combine Immunodeficiency
Infants with severe combined immunodeficiency are unable
to mount an adaptive immune response, because they have a
profound deficiency of lymphocytes.
Attempt of gene therapy for immunodeficiency was
successful in children with severe combined
immunodeficiency due to a deficiency of adenosine
deaminase.
GENE THERAPY 32
Multiple gene therapy strategies have been developed to treat a wide variety of cancers.
Phase III trial for head and neck cancer Phase III gene vaccine trials for prostate cancer and pancreas cancer.
Additionally, numerous Phase I and Phase II clinical trials for cancers in the brain, skin, liver, colon, breast and kidney are being conducted .
cancer
GENE THERAPY 33
Gene Therapy in Heart Failure
Gene therapy in HF must be aimed at correcting key molecular mechanisms in cardiac tissue.
This requires,introduction of DNA/RNA that targets specific cardiomyocyte processes that alter HF outcomes.
GENE THERAPY 34
Gene delivery and activation. Introducing changes into the germline. Immune response. Disrupting important genes in target cells. Success requires -efficient delivery, - the correct gene, -the correct cells, -the correct tissue,
Challenges in Gene Therapy
GENE THERAPY 35
Conclusion
The viral and non viral gene delivery strategies have been fairly
successful in cell culture systems and animal models
The therapeutic success of GT in human still remains
questionable.
With the explosive increase in the availability of information on
human genome, several genetic disorder have become
candidates for gene therapy.
GENE THERAPY 36
The field is still at its infancy, the need of the hour is to initiate
more studies in different systems on the various aspects.
In spite of various drawbacks, gene therapy is witnessing a
rapid growth and hope fully the progress would continue.
Conclusion….
GENE THERAPY 37
References
Vyas S. P. , Dixit V. K., Pharmaceutical Biotechnology 1st edition, CBS Publisher & distributors 2001, New Delhi,401-435
D’Souza J.I. , Killedar S. J., Biotechnology & Fermentation Process 3rd edition, Nirali Prakashan Pune. 2007, 7.1-7.32
K.Sambamurthy, Ashutosh Kar.“ Pharmaceutical Biotechnology”,2nd Edn.,New Age International Publishers123-135.
U.Satyanarayana Biotechnology 3rd edition uppala author publishers.
38
THANK YOU